Last reviewed · How we verify
Combination of SH003 and Docetaxel — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Combination of SH003 and Docetaxel (Combination of SH003 and Docetaxel) — Kyunghee University Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Combination of SH003 and Docetaxel TARGET | Combination of SH003 and Docetaxel | Kyunghee University Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Combination of SH003 and Docetaxel CI watch — RSS
- Combination of SH003 and Docetaxel CI watch — Atom
- Combination of SH003 and Docetaxel CI watch — JSON
- Combination of SH003 and Docetaxel alone — RSS
Cite this brief
Drug Landscape (2026). Combination of SH003 and Docetaxel — Competitive Intelligence Brief. https://druglandscape.com/ci/combination-of-sh003-and-docetaxel. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab